Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Burge

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Delaware Medical Journal|November 1, 1991
Wegener's granulomatosisD J Burge
Cardiovascular Clinics|January 1, 1993
Acute rheumatic feverD J Burge, R J DeHoratius
Lancet (London, England)|September 6, 2000
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trialP J Mease, B S Goffe, J Metz, et al.
The New England Journal of Medicine|January 28, 1999
A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexateM E Weinblatt, J M Kremer, A D Bankhurst, et al.
Lupus|November 18, 2016
Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled studyD J Burge, J Eisenman, K Byrnes-Blake, et al.
The Journal of Rheumatology|June 21, 2001
Long-term safety and efficacy of etanercept in patients with rheumatoid arthritisL W Moreland, S B Cohen, S W Baumgartner, et al.
Annals of Internal Medicine|March 13, 1999
Etanercept therapy in rheumatoid arthritis. A randomized, controlled trialL W Moreland, M H Schiff, S W Baumgartner, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Delaware Medical Journal|November 1, 1991
Wegener's granulomatosisD J Burge
Cardiovascular Clinics|January 1, 1993
Acute rheumatic feverD J Burge, R J DeHoratius
Lancet (London, England)|September 6, 2000
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trialP J Mease, B S Goffe, J Metz, et al.
The New England Journal of Medicine|January 28, 1999
A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexateM E Weinblatt, J M Kremer, A D Bankhurst, et al.
Lupus|November 18, 2016
Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled studyD J Burge, J Eisenman, K Byrnes-Blake, et al.
The Journal of Rheumatology|June 21, 2001
Long-term safety and efficacy of etanercept in patients with rheumatoid arthritisL W Moreland, S B Cohen, S W Baumgartner, et al.
Annals of Internal Medicine|March 13, 1999
Etanercept therapy in rheumatoid arthritis. A randomized, controlled trialL W Moreland, M H Schiff, S W Baumgartner, et al.
Pageof 1